Who Paid My Doc
Phase P3 Pediatric Study EM
Research payments
$636,205
Through program year 2024, $636,205 in research payments was reported against Phase P3 Pediatric Study EM, across 78 payments, paid by Amgen Inc..
- Paid by
- Amgen Inc.
- ClinicalTrials.gov
- No trial number was reported for this study
By program year
1 row| Year | Kind | Amount | Payments |
|---|---|---|---|
| 2024 | Research | $636,205 | 78 |
Breakdown
Usually the institution or organisation running the study, not a person.
Records
Every payment, record by record
Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.
Principal investigators named
10 shownNamed on the study's payments. Being named is not being paid: the money in the figures above went to the recipients listed, not necessarily to these people.
- Alma Bicknese Chicago, IL Named on 4 payments
- Daniel Leonard Hastings, NE Named on 4 payments
- Marc Disabella Washington, DC Named on 4 payments
- Weldon Mauney Gulf Breeze, FL Named on 4 payments
- Barry Vaught Crab Orchard, WV Named on 3 payments
- Katherine Bencze Tampa, FL Named on 3 payments
- Joel Saper Ann Arbor, MI Named on 3 payments
- Bradley Torphy Chicago, IL Named on 3 payments
- Robert Carlile Summerville, SC Named on 3 payments
- Ryan Williams Norfolk, VA Named on 3 payments
What you are looking at
Research payments are tied to a study. Being named on a study as a principal investigator is reported separately from being paid as a recipient, and the two are not the same thing — a named investigator has not necessarily received the money.